Total Payments
$683.61
2023 Payments
$453.99
Companies
9
Transactions
37

Payment Breakdown by Category

Food & Beverage$656.55 (96.0%)
Other$27.06 (4.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $656.55 36 96.0%
Debt forgiveness $27.06 1 4.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $356.71 19 $0 (2023)
AstraZeneca Pharmaceuticals LP $96.96 6 $0 (2023)
Novo Nordisk Inc $72.31 4 $0 (2023)
Corium, LLC $43.14 2 $0 (2023)
Lilly USA, LLC $39.90 2 $0 (2022)
Baxter Healthcare $27.06 1 $0 (2022)
IDORSIA PHARMACEUTICALS US INC $17.99 1 $0 (2023)
GlaxoSmithKline, LLC. $16.70 1 $0 (2023)
Biohaven Pharmaceuticals, Inc. $12.84 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2023 $453.99 27 ABBVIE INC. ($275.98)
2022 $136.05 7 AstraZeneca Pharmaceuticals LP ($50.46)
2021 $93.57 3 AbbVie Inc. ($80.73)

All Payment Transactions

37 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/17/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $16.54 General
Category: NEUROSCIENCE
10/27/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $25.30 General
Category: NEUROSCIENCE
10/23/2023 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $24.27 General
Category: NEUROSCIENCE
10/02/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $5.35 General
Category: NEUROSCIENCE
09/27/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $15.75 General
Category: Respiratory
09/23/2023 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $33.81 General
Category: CNS Stimulant for ADHD
09/21/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $27.55 General
Category: NEUROSCIENCE
09/15/2023 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $12.32 General
Category: NEUROSCIENCE
09/11/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $4.75 General
Category: NEUROSCIENCE
08/25/2023 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $13.65 General
Category: NEUROSCIENCE
08/11/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.83 General
Category: NEUROSCIENCE
08/10/2023 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $9.33 General
Category: CNS Stimulant for ADHD
08/04/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $9.48 General
Category: NEUROSCIENCE
07/24/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $17.21 General
Category: Diabetes
06/20/2023 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $12.11 General
Category: NEUROSCIENCE
06/02/2023 GlaxoSmithKline, LLC. SHINGRIX (Biological) Food and Beverage In-kind items and services $16.70 General
Category: VACCINES
05/23/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $18.85 General
Category: NEUROSCIENCE
04/25/2023 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $18.82 General
Category: Diabetes
04/18/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $8.58 General
Category: NEUROSCIENCE
04/05/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $13.64 General
Category: Respiratory
03/31/2023 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $19.80 General
Category: NEUROSCIENCE
03/24/2023 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $17.99 General
Category: INSOMNIA
03/22/2023 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $17.65 General
Category: Obesity
03/06/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $4.38 General
Category: NEUROSCIENCE
02/06/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $34.28 General
Category: NEUROSCIENCE

About Emily Linker

Emily Linker is a Student in an Organized Health Care Education/Training Program healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2019. The National Provider Identifier (NPI) number assigned to this provider is 1003461534.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Emily Linker has received a total of $683.61 in payments from pharmaceutical and medical device companies, with $453.99 received in 2023. These payments were reported across 37 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($656.55).

Practice Information

Products in Payments

  • VRAYLAR (Drug) $257.62
  • QULIPTA (Drug) $74.82
  • Azstarys (Drug) $43.14
  • BREZTRI (Drug) $43.12
  • FASENRA (Biological) $38.02
  • Rybelsus (Drug) $35.84
  • UBRELVY (Drug) $24.27
  • MOUNJARO (Drug) $22.18
  • Ozempic (Drug) $18.82
  • QUVIVIQ (Drug) $17.99
  • EMGALITY (Drug) $17.72
  • Wegovy (Drug) $17.65
  • SHINGRIX (Biological) $16.70
  • FARXIGA (Drug) $15.82
  • NURTEC ODT (Drug) $12.84

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Austin